This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (488)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Alzheimer Disease  • Cognitive Disorders  • Prognosis/ Outcomes  • Aging/ Geriatrics  • Alert me on articles by topic

John C. Morris, MD; Martha Storandt, PhD; J. Phillip Miller; Daniel W. McKeel, MD; Joseph L. Price, PhD; Eugene H. Rubin, MD, PhD; Leonard Berg, MD

Arch Neurol. 2001;58:397-405.

Background  Mild cognitive impairment (MCI) is considered to be a transitional stage between aging and Alzheimer disease (AD).

Objective  To determine whether MCI represents early-stage AD by examining its natural history and neuropathologic basis.

Design  A prospective clinical and psychometric study of community-living elderly volunteers, both nondemented and minimally cognitively impaired, followed up for up to 9.5 years. Neuropathologic examinations were performed on participants who had undergone autopsy.

Setting  An AD research center.

Participants  All participants enrolled between July 1990 and June 1997 with Clinical Dementia Rating (CDR) scores of 0 (cognitively healthy; n = 177; mean age, 78.9 years) or 0.5 (equivalent to MCI; n = 277; mean age, 76.9 years). Based on the degree of clinical confidence that MCI represented dementia of the Alzheimer type (DAT), 3 subgroups of individuals with CDR scores of 0.5 were identified: CDR 0.5/DAT, CDR 0.5/incipient DAT, and CDR 0.5/uncertain dementia.

Main Outcome Measure  Progression to the stage of CDR 1, which characterizes mild definite DAT.

Results  Survival analysis showed that 100% of CDR 0.5/DAT participants progressed to greater dementia severity over a 9.5-year period. At 5 years, rates of progression to a score of CDR 1 (or greater) for DAT were 60.5% (95% confidence interval [CI], 50.2%-70.8%) for the CDR 0.5/DAT group, 35.7% (95% CI, 21.0%-50.3%) for the CDR 0.5/incipient DAT group, 19.9% (95% CI, 8.0%-31.8%) for the CDR 0.5/uncertain dementia group, and 6.8% (95% CI, 2.2%-11.3%) for CDR 0/controls. Progression to greater dementia severity correlated with degree of cognitive impairment at baseline. Twenty-four of the 25 participants with scores of CDR 0.5 had a neuropathologic dementing disorder, which was AD in 21 (84%).

Conclusions  Individuals currently characterized as having MCI progress steadily to greater stages of dementia severity at rates dependent on the level of cognitive impairment at entry and they almost always have the neuropathologic features of AD. We conclude that MCI generally represents early-stage AD.

From the Departments of Neurology (Drs Morris, Storandt, and Berg), Psychology (Dr Storandt), Pathology (Drs Morris and McKeel), Anatomy and Neurobiology (Dr Price), and Psychiatry (Dr Rubin), Division of Biostatistics (Mr Miller), and Alzheimer's Disease Research Center (Drs Morris, Storandt, McKeel, Price, Rubin, and Berg and Mr Miller), Washington University, St Louis, Mo.

Corresponding author and reprints: John C. Morris, MD, Alzheimer's Disease Research Center, Washington University School of Medicine, 4488 Forest Park Ave, Suite 130, St Louis, MO 63178.

RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 2001;58(3):523-525.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vascular Subcortical Hyperintensities Predict Conversion to Vascular and Mixed Dementia in MCI Patients
Bombois et al.
Stroke 2008;39:2046-2051.
ABSTRACT | FULL TEXT  

Smoking History and Cognitive Function in Middle Age From the Whitehall II Study
Sabia et al.
Arch Intern Med 2008;168:1165-1173.
ABSTRACT | FULL TEXT  

Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia
Chertkow et al.
CMAJ 2008;178:1273-1285.
ABSTRACT | FULL TEXT  

Patients with MCI and N400 or P600 abnormalities are at very high risk for conversion to dementia
Olichney et al.
Neurology 2008;70:1763-1770.
ABSTRACT | FULL TEXT  

Association of Blood Pressure and Genetic Background With White Matter Lesions in Patients With Mild Cognitive Impairment
Galluzzi et al.
J. Gerontol. A Biol. Sci. Med. Sci. 2008;63:510-517.
ABSTRACT | FULL TEXT  

Characterization of Activities of Daily Living in Individuals With Mild Cognitive Impairment
Jefferson et al.
AJGP 2008;16:375-383.
ABSTRACT | FULL TEXT  

Potential Role of Diffusion Tensor MRI in the Differential Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
B. Parente et al.
Am. J. Roentgenol. 2008;190:1369-1374.
ABSTRACT | FULL TEXT  

Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's Disease
He et al.
J. Neurosci. 2008;28:4756-4766.
ABSTRACT | FULL TEXT  

A Two-Year Study with Fibrillar {beta}-Amyloid (A{beta}) Immunization in Aged Canines: Effects on Cognitive Function and Brain A{beta}
Head et al.
J. Neurosci. 2008;28:3555-3566.
ABSTRACT | FULL TEXT  

Mild Cognitive Dysfunction: An Epidemiological Perspective With an Emphasis on African Americans
Unverzagt et al.
J Geriatr Psychiatry Neurol 2007;20:215-226.
ABSTRACT  

Clinical Prediction of Alzheimer Disease Dementia Across the Spectrum of Mild Cognitive Impairment
Dickerson et al.
Arch Gen Psychiatry 2007;64:1443-1450.
ABSTRACT | FULL TEXT  

Amnestic syndrome of the medial temporal type identifies prodromal AD: A longitudinal study
Sarazin et al.
Neurology 2007;69:1859-1867.
ABSTRACT | FULL TEXT  

The Power of Personality in Discriminating Between Healthy Aging and Early-Stage Alzheimer's Disease
Duchek et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2007;62:P353-P361.
ABSTRACT | FULL TEXT  

Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia
Goodenowe et al.
J. Lipid Res. 2007;48:2485-2498.
ABSTRACT | FULL TEXT  

Neurocognitive Impairment and Dementia in Mood Disorders
Pfennig et al.
J. Neuropsychiatry Clin. Neurosi. 2007;19:373-382.
ABSTRACT | FULL TEXT  

Reduced Hippocampal Functional Connectivity in Alzheimer Disease
Allen et al.
Arch Neurol 2007;64:1482-1487.
ABSTRACT | FULL TEXT  

Peripheral insulin and brain structure in early Alzheimer disease
Burns et al.
Neurology 2007;69:1094-1104.
ABSTRACT | FULL TEXT  

Open Access Series of Imaging Studies (OASIS): Cross-sectional MRI Data in Young, Middle Aged, Nondemented, and Demented Older Adults.
Marcus et al.
J. Cogn. Neurosci. 2007;19:1498-1507.
ABSTRACT | FULL TEXT  

Plasma Homocysteine Is Associated with the Risk of Mild Cognitive Impairment in an Elderly Korean Population
Kim et al.
J. Nutr. 2007;137:2093-2097.
ABSTRACT | FULL TEXT  

A{beta} amyloid deposition in the language system and how the brain responds
Nelissen et al.
Brain 2007;130:2055-2069.
ABSTRACT | FULL TEXT  

Characteristic Profiles of Instrumental Activities of Daily Living in Chinese Older Persons with Mild Cognitive Impairment
Woon Chi Tam et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2007;22:211-217.
ABSTRACT  

Conversion to Dementia From Questionable Dementia in an Ethnic Chinese Population
Liu et al.
J Geriatr Psychiatry Neurol 2007;20:76-83.
ABSTRACT  

Cerebral Metabolic Correlates of the Clinical Dementia Rating Scale in Mild Cognitive Impairment
Perneczky et al.
J Geriatr Psychiatry Neurol 2007;20:84-88.
ABSTRACT  

Transitions to Mild Cognitive Impairments, Dementia, and Death: Findings from the Nun Study
Tyas et al.
Am J Epidemiol 2007;165:1231-1238.
ABSTRACT | FULL TEXT  

Should One Use Medications in Combination With Cognitive Training? If So, Which Ones?
Yesavage et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2007;62:11-18.
ABSTRACT | FULL TEXT  

Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease
Galvin et al.
Neurology 2007;68:1895-1901.
ABSTRACT | FULL TEXT  

CIND and MCI in the Italian elderly: Frequency, vascular risk factors, progression to dementia
Di Carlo et al.
Neurology 2007;68:1909-1916.
ABSTRACT | FULL TEXT  

Evaluation of Cognitive Impairment in Older Adults: Combining Brief Informant and Performance Measures
Galvin et al.
Arch Neurol 2007;64:718-724.
ABSTRACT | FULL TEXT  

Patient's Rating of Cognitive Ability: Using the AD8, a Brief Informant Interview, as a Self-rating Tool to Detect Dementia
Galvin et al.
Arch Neurol 2007;64:725-730.
ABSTRACT | FULL TEXT  

Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff et al.
Neurology 2007;68:1501-1508.
ABSTRACT | FULL TEXT  

Activation of Caspase-6 in Aging and Mild Cognitive Impairment
Albrecht et al.
Am. J. Pathol. 2007;170:1200-1209.
ABSTRACT | FULL TEXT  

Cortical biochemistry in MCI and Alzheimer disease: Lack of correlation with clinical diagnosis
Forman et al.
Neurology 2007;68:757-763.
ABSTRACT | FULL TEXT  

Spatial navigation deficit in amnestic mild cognitive impairment
Hort et al.
Proc. Natl. Acad. Sci. USA 2007;104:4042-4047.
ABSTRACT | FULL TEXT  

Incidence of Dementia in Mild Cognitive Impairment in the Cardiovascular Health Study Cognition Study
Lopez et al.
Arch Neurol 2007;64:416-420.
ABSTRACT | FULL TEXT  

Word Reading and Posterior Temporal Dysfunction in Amnestic Mild Cognitive Impairment
Vandenbulcke et al.
Cereb Cortex 2007;17:542-551.
ABSTRACT | FULL TEXT  

Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia
Golob et al.
Brain 2007;130:740-752.
ABSTRACT | FULL TEXT  

Qualitative Estimates of Medial Temporal Atrophy as a Predictor of Progression From Mild Cognitive Impairment to Dementia
DeCarli et al.
Arch Neurol 2007;64:108-115.
ABSTRACT | FULL TEXT  

Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease
Williams et al.
Neurology 2006;67:1935-1941.
ABSTRACT | FULL TEXT  

Validity and reliability of the AD8 informant interview in dementia
Galvin et al.
Neurology 2006;67:1942-1948.
ABSTRACT | FULL TEXT  

Plasma Cortisol and Progression of Dementia in Subjects With Alzheimer-Type Dementia
Csernansky et al.
Am. J. Psychiatry 2006;163:2164-2169.
ABSTRACT | FULL TEXT  

Making Sense of Mild Cognitive Impairment: A Qualitative Exploration of the Patient's Experience
Lingler et al.
Gerontologist 2006;46:791-800.
ABSTRACT | FULL TEXT  

Clinical phenotype of Parkinson disease dementia.
Galvin et al.
Neurology 2006;67:1605-1611.
ABSTRACT | FULL TEXT  

Using Different Memory Cutoffs to Assess Mild Cognitive Impairment.
Loewenstein et al.
AJGP 2006;14:911-919.
ABSTRACT | FULL TEXT  

Ten-year risk of dementia in subjects with mild cognitive impairment.
Visser et al.
Neurology 2006;67:1201-1207.
ABSTRACT | FULL TEXT  

Mild cognitive impairment: Risk of Alzheimer disease and rate of cognitive decline
Boyle et al.
Neurology 2006;67:441-445.
ABSTRACT | FULL TEXT  

[11C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun et al.
Neurology 2006;67:446-452.
ABSTRACT | FULL TEXT  

Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI
Storandt et al.
Neurology 2006;67:467-473.
ABSTRACT | FULL TEXT  

Insight and cognitive impairment: effects on quality-of-life reports from mild cognitive impairment and Alzheimer's disease patients.
Ready et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:242-248.
ABSTRACT  

Conversion to dementia from mild cognitive disorder: the Cache County Study.
Tschanz et al.
Neurology 2006;67:229-234.
ABSTRACT | FULL TEXT  

Handwriting process variables discriminating mild Alzheimer's disease and mild cognitive impairment.
Werner et al.
J. Gerontol. B Psychol. Sci. Soc. Sci. 2006;61:P228-P236.
ABSTRACT | FULL TEXT  

Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease
Portet et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:714-718.
ABSTRACT | FULL TEXT  

Neuropsychological Markers of Progression From Mild Cognitive Impairment to Alzheimer's Disease
Marcos et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:189-196.
ABSTRACT  

Verbal learning and everyday functioning in dementia: an application of latent variable growth curve modeling.
Mast and Allaire
J. Gerontol. B Psychol. Sci. Soc. Sci. 2006;61:P167-P173.
ABSTRACT | FULL TEXT  

Neuropathologic Features of Amnestic Mild Cognitive Impairment
Petersen et al.
Arch Neurol 2006;63:665-672.
ABSTRACT | FULL TEXT  

Complex activities of daily living in mild cognitive impairment: conceptual and diagnostic issues
Perneczky et al.
Age Ageing 2006;35:240-245.
ABSTRACT | FULL TEXT  

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
Galimberti et al.
Arch Neurol 2006;63:538-543.
ABSTRACT | FULL TEXT  

Recognition and treatment of Alzheimer's disease: A case-based review
Marseille and Silverman
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:119-125.
ABSTRACT  

Magnetoencephalographic Parietal {delta} Dipole Density in Mild Cognitive Impairment: Preliminary Results of a Method to Estimate the Risk of Developing Alzheimer Disease.
Fernandez et al.
Arch Neurol 2006;63:427-430.
ABSTRACT | FULL TEXT  

Combination of Clinical and Neuropsychologic Information as a Better Predictor of the Progression to Alzheimer Disease in Questionable Dementia Individuals
Lee et al.
AJGP 2006;14:130-138.
ABSTRACT | FULL TEXT  

Discriminative and predictive power of an informant report in mild cognitive impairment
Isella et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:166-171.
ABSTRACT | FULL TEXT  

Neuropsychological characteristics of mild cognitive impairment subgroups
Lopez et al.
J. Neurol. Neurosurg. Psychiatry 2006;77:159-165.
ABSTRACT | FULL TEXT  

Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline
Steffens et al.
Arch Gen Psychiatry 2006;63:130-138.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment Is Early-Stage Alzheimer Disease: Time to Revise Diagnostic Criteria
Morris
Arch Neurol 2006;63:15-16.
FULL TEXT  

Neuropathologic Substrate of Mild Cognitive Impairment
Markesbery et al.
Arch Neurol 2006;63:38-46.
ABSTRACT | FULL TEXT  

The Neuropathology of Alzheimer Disease in African American and White Individuals
Wilkins et al.
Arch Neurol 2006;63:87-90.
ABSTRACT | FULL TEXT  

Three-dimensional Patterns of Hippocampal Atrophy in Mild Cognitive Impairment
Becker et al.
Arch Neurol 2006;63:97-101.
ABSTRACT | FULL TEXT  

Antecedent Biomarkers of Alzheimer's Disease: The Adult Children Study
Coats and Morris
J Geriatr Psychiatry Neurol 2005;18:242-244.
ABSTRACT  

Effects of Physical Activity on Cognitive Functioning in Middle Age: Evidence From the Whitehall II Prospective Cohort Study
Singh-Manoux et al.
Am. J. Public Health 2005;95:2252-2258.
ABSTRACT | FULL TEXT  

White Matter Lesions Are Prevalent but Differentially Related With Cognition in Aging and Early Alzheimer Disease
Burns et al.
Arch Neurol 2005;62:1870-1876.
ABSTRACT | FULL TEXT  

The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition
Nordlund et al.
J. Neurol. Neurosurg. Psychiatry 2005;76:1485-1490.
ABSTRACT | FULL TEXT  

Implementing Diagnostic Criteria and Estimating Frequency of Mild Cognitive Impairment in an Urban Community
Manly et al.
Arch Neurol 2005;62:1739-1746.
ABSTRACT | FULL TEXT  

Ribosome Dysfunction Is an Early Event in Alzheimer's Disease
Ding et al.
J. Neurosci. 2005;25:9171-9175.
ABSTRACT | FULL TEXT  

The staging and assessment of moderate to severe Alzheimer disease
Feldman and Woodward
Neurology 2005;65:S10-S17.
ABSTRACT | FULL TEXT  

Effects of galantamine on working memory and global functioning in patients with mild cognitive impairment: A double-blind placebo-controlled study
Koontz and Baskys
AM J ALZHEIMERS DIS OTHER DEMEN 2005;20:295-302.
ABSTRACT  

Differential Cortical Atrophy in Subgroups of Mild Cognitive Impairment
Bell-McGinty et al.
Arch Neurol 2005;62:1393-1397.
ABSTRACT | FULL TEXT  

Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory
Buckner et al.
J. Neurosci. 2005;25:7709-7717.
ABSTRACT | FULL TEXT  

The AD8: A brief informant interview to detect dementia
Galvin et al.
Neurology 2005;65:559-564.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment
Schneider
AJGP 2005;13:629-632.
FULL TEXT  

Current Epidemiology of Mild Cognitive Impairment and Other Predementia Syndromes
Panza et al.
AJGP 2005;13:633-644.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment
Feldman and Jacova
AJGP 2005;13:645-655.
ABSTRACT | FULL TEXT  

Cognitive Status, Depressive Symptoms, and Health Status as Predictors of Functional Disability Among Elderly Persons With Low-to-Moderate Education: The Faenza Community Aging Study
De Ronchi et al.
AJGP 2005;13:672-685.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment as a Clinical Entity and Treatment Target
Petersen and Morris
Arch Neurol 2005;62:1160-1163.
FULL TEXT  

Mild Cognitive Impairment Is Not a Clinical Entity and Should Not Be Treated
Gauthier and Touchon
Arch Neurol 2005;62:1164-1166.
FULL TEXT  

Frontal-Hippocampal Double Dissociation Between Normal Aging and Alzheimer's Disease
Head et al.
Cereb Cortex 2005;15:732-739.
ABSTRACT | FULL TEXT  

The functional anatomy of divided attention in amnestic mild cognitive impairment
Dannhauser et al.
Brain 2005;128:1418-1427.
ABSTRACT | FULL TEXT  

Predictors of Preclinical Alzheimer Disease and Dementia: A Clinicopathologic Study
Galvin et al.
Arch Neurol 2005;62:758-765.
ABSTRACT | FULL TEXT  

The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs
Burns et al.
Neurology 2005;64:1397-1403.
ABSTRACT | FULL TEXT  

Cognitive status correlates with neuropathologic stage in Parkinson disease
Braak et al.
Neurology 2005;64:1404-1410.
ABSTRACT | FULL TEXT  

Evidence of increased oxidative damage in subjects with mild cognitive impairment
Keller et al.
Neurology 2005;64:1152-1156.
ABSTRACT | FULL TEXT  

CSF A{beta}42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment
Herukka et al.
Neurology 2005;64:1294-1297.
ABSTRACT | FULL TEXT  

Conversion From Mild Cognitive Impairment to Probable Alzheimer's Disease Predicted by Brain Magnetic Resonance Spectroscopy
Modrego et al.
Am. J. Psychiatry 2005;162:667-675.
ABSTRACT | FULL TEXT  

Effect of Raloxifene on Prevention of Dementia and Cognitive Impairment in Older Women: The Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial
Yaffe et al.
Am. J. Psychiatry 2005;162:683-690.
ABSTRACT | FULL TEXT  

Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
Fotenos et al.
Neurology 2005;64:1032-1039.
ABSTRACT | FULL TEXT  

Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions
Bennett et al.
Neurology 2005;64:834-841.
ABSTRACT | FULL TEXT  

DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment
Kantarci et al.
Neurology 2005;64:902-904.
ABSTRACT | FULL TEXT